Table 1.
Clinical topic | Guideline | User type, no.* | ||
---|---|---|---|---|
Clinicians†n = 28 | Researchers and developers‡n = 38 | Policy-makers§n = 17 | ||
Cancer | A | 15 | 38 | 17 |
B | ||||
C | ||||
D | ||||
Cardiovascular | E | 7 | – | |
F | ||||
G | ||||
H | ||||
Critical care | I | 6 | – | |
J |
Participants of each user type were randomly assigned to guidelines as indicated by clinical topic.
The areas of expertise of clinicians were matched to clinical topic.
Researchers and developers were randomly assigned to clinical topics.
Policy-makers were allocated only to the clinical topic of cancer.